Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cellebrite DI Ltd shares valued at $331,430 were purchased by Ben-Peretz Leeor on Nov 13 ’24. At $18.58 per share, Ben-Peretz Leeor acquired 17,838 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Gerner Dana purchased 38,804 shares, netting a total of over 720,978 in proceeds.
Before that, Carmil Yosef had added 74,206 shares to its account. In a trade valued at $1,378,747, the Officer bought Cellebrite DI Ltd shares for $18.58 each.
As published in a research note from Needham on March 28, 2024, Cellebrite DI Ltd [CLBT] has been retained to a Buy and the price target has been revised to $13.50. Analysts at William Blair upgraded the stock from ‘”a Mkt perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid March. As of February 16, 2024, BofA Securities has increased its “Neutral” rating to a “Buy” for CLBT. Earlier on July 19, 2023, Craig Hallum initiated its rating. Their recommendation was “a Buy” for CLBT stock.
Analyzing CLBT Stock Performance
During the last five days, there has been a drop of approximately -4.42%. Over the course of the year, Cellebrite DI Ltd shares have jumped approximately 107.39%. Shares of the company reached a 52-week high of $21.00 on 11/06/24 and a 52-week low of $7.91 on 01/17/24. A 50-day SMA is recorded $17.72, while a 200-day SMA reached $13.46. Nevertheless, trading volume fell to 1.09 million shares from 1.86 million shares the previous day.
Support And Resistance Levels for Cellebrite DI Ltd (CLBT)
According to the 24-hour chart, there is a support level at 17.52, which, if violated, would cause prices to drop to 17.07. In the upper region, resistance lies at 18.34. The next price resistance is at 18.71. RSI (Relative Strength Index) is 47.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.36, which suggests the price will decrease in the coming days. Percent R is at 85.63%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
